Welcome to our dedicated page for Jushi Hldgs news (Ticker: JUSHF), a resource for investors and traders seeking the latest updates and insights on Jushi Hldgs stock.
Jushi Holdings Inc. reports operating, financial, and governance developments as a vertically integrated, multi-state cannabis operator traded on the OTCQX under JUSHF. Company updates cover quarterly and annual results, dispensary openings, cultivation performance, product availability, Jushi-branded cannabis products, and regulatory developments in state cannabis markets.
Recurring announcements also address capital structure and liquidity actions, including debt arrangements, subordinate voting share disclosures, executive compensation matters, early warning reports, shareholder voting topics, and other governance events tied to the company’s public-company reporting.
Jushi (OTCQX:JUSHF)/b) celebrates Virginia’s enactment of legislation creating a regulated adult-use cannabis market, with licensed sales scheduled to start on . Virginia becomes the first Southern state with such a market.
Jushi highlights its existing cultivation, manufacturing and retail footprint and plans a multiphase Virginia cultivation expansion exceeding 250%, including a 33% cultivation space increase this year, a canopy doubling next year, and evaluation of a secured greenhouse property to support future production.
Jushi Holdings (OTCQX:JUSHF) released voting results from its June 24, 2026 annual general and special shareholders’ meeting.
Shareholders set the board size at five directors, elected all nominated directors, ratified Macias Gini & O’Connell LLP as auditors, and approved the Company’s redomicile from British Columbia to Nevada by special resolution.
Jushi Holdings (OTCQX:JUSHF) submitted applications to the U.S. DEA for registration of certain state-licensed medical marijuana operations under the new Schedule III federal framework. The move aims to align its medical cannabis activities with evolving federal regulations while continuing to serve patients under applicable state laws.
Jushi Holdings (OTCQX:JUSHF) reported Q1 2026 revenue of $66.4 million, up 4% year-over-year, with gross profit of $29.9 million and a 45.0% gross margin, expanding 460 bps. Net loss was $19.8 million, while Adjusted EBITDA reached $11.4 million (17.2% margin).
The Company refinanced prior debt with a $160 million secured term loan due 2029, ended the quarter with $42.3 million in cash, and generated $8.6 million in operating cash flow. Medical marijuana’s move to Schedule III is expected to reduce ongoing tax expense.
James Cacioppo (JUSHF) filed an updated early warning report dated May 8, 2026 describing share and option changes tied to a December 11, 2025 employment amendment. The amendment converted a US$1,050,000 bonus into a US$300,000 cash payment and 3,000,000 restricted subordinate voting shares that vested January 1, 2026. The filing reports aggregate holdings and exercise restrictions (a blocker limiting beneficial ownership above certain thresholds) and confirms beneficial ownership at 19.99% following a prior increase to that Maximum Percentage.
Jushi Holdings (OTCQX: JUSHF) will report first quarter 2026 financial results after market close on Tuesday, May 12, 2026. Management will host a conference call and audio webcast that day at 4:30 p.m. ET. A replay webcast will be available through June 12, 2026 on Jushi’s investor relations site.
Jushi Holdings (OTCQX: JUSHF) announced a proposed arrangement to continue from British Columbia to Nevada, subject to shareholder (66 2/3% vote) and court approvals. Each existing subordinate voting share will convert 1:1 into Nevada common stock and options/warrants will be adjusted equally. The company said the move aligns corporate domicile with its U.S.-focused operations, intends to file a Proxy Statement on SEDAR+ and Schedule 14A on EDGAR, and expects Nevada common stock to trade on the Canadian Securities Exchange and be quoted on the OTCQX under the same symbols after completion.
Jushi Holdings (OTCQX:JUSHF) applauds President Donald J. Trump and his administration for finalizing the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act on April 23, 2026. Jushi calls the change historic, saying it recognizes medical value, expands patient access, and unlocks federally supported research while noting rescheduling does not legalize cannabis federally.
The company says rescheduling should remove burdensome tax penalties and create reinvestment opportunities for state cannabis programs, while Jushi plans engagement with state lawmakers resisting reform.
Jushi Holdings (OTCQX: JUSHF) reported Q4 2025 and FY 2025 results: FY revenue $262.9M (+2% YoY), Q4 revenue $68.3M, FY gross profit $114.0M, FY net loss $(68.6)M, and FY Adjusted EBITDA $50.3M (19.1% margin). The company refinanced debt in March 2026 with a $160.0M term loan due 2029 to extend maturities and bolster liquidity.
Operational gains included improved cultivation performance, 8 new stores since Q3 2024 (42 total), and branded products at ~57-58% of retail sales.
Jushi (OTCQX:JUSHF) refinanced its former first- and second-lien credit facilities with a US$160 million senior secured term loan that carries a 12.50% interest rate, a 4.0% original issuance discount and a three-year maturity. The Term Loan is non-amortizing and non-dilutive.
Following repayment of the prior facilities, the company reported approximately $35 million of cash, cash equivalents and restricted cash as of March 27, 2026. Related parties, including the CEO and a founder, participated in the Term Loan.